Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus esmolol vs remimazolam alone for anesthesia induction hemodynamics
ChiCTR2400092369Phase 4Completed
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and esmolol in cardiac morbidity (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Mean arterial pressure and Heart rate. Started Nov 2024; status: completed.
02
Drugs
remimazolamesmolol
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ChiCTR2400092369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092369.